A friend passed this on to me today. It was written by David Thompson who is a partner at Hunt and Hunt Lawyers. Unfortunatley I could not cut and paste this so I have had to re type it.
A decision handed down In the Australian IRC on 25/08/08 could bring about the end of urine testing for drugs and alcohol in the workplace in the near future (Shell Refining Australia pty ltd -v- CFMEU), if the reasoning of SDP Hamburger is adopted by the full bench of the AIRC or the Federal Court.
In his decision , he rejected the reasoning in a 10 year old often cited precedent decision of the WA IRC in the BHP Iron Ore case. In that deceision WAIRC found that a random testing program using urine samples was justified on safety grounds and was both fair and reasonable. In this case, SDP Hamburgerfound that in the last decade, oral fluid (saliva) testing has become availableand an Australian Standard for this testing has been developed. He found that it would be unjust and unreasonablefor the company to implement a urine based random testing regime at its Clyde refinery. with its wide "window of detection" and all that implies for interfering with the private lives of employees. Inhis view a more focussed method (saliva testing), is available where a positve test is far more likley to indicate actual impairment.
This conclusion was based on eveidence that drugs can be detected in urine well beyond the time the drug is having a significant biological effect. For example, the detection time for cannaboids in urine is 3 to 28 days, whereas for saliva it is up to 12 hours. For Meth, the detection time in urine is 2-5 days and only 24 hrs in saliva.
The decision was subject to 2 qualifications:
(a) Firstly, at this stage, no laboratories have as yet been accreditied under the relevant Australian Standards for saliva testing. It is understood this will change in the relatively near future.
(b) Secondly, there are drugs that the company may wish to test for (such as benzodiazapans) for which the Australian standard does not contain target concentration levels. The company should not be expected to implement a saliva testing regime until it has the agreement of the union and the testing lab on what other drugs it wishes to test for and what would be an appropriate target concentration level.
Will post remainder in the morning. Cant type any more
A decision handed down In the Australian IRC on 25/08/08 could bring about the end of urine testing for drugs and alcohol in the workplace in the near future (Shell Refining Australia pty ltd -v- CFMEU), if the reasoning of SDP Hamburger is adopted by the full bench of the AIRC or the Federal Court.
In his decision , he rejected the reasoning in a 10 year old often cited precedent decision of the WA IRC in the BHP Iron Ore case. In that deceision WAIRC found that a random testing program using urine samples was justified on safety grounds and was both fair and reasonable. In this case, SDP Hamburgerfound that in the last decade, oral fluid (saliva) testing has become availableand an Australian Standard for this testing has been developed. He found that it would be unjust and unreasonablefor the company to implement a urine based random testing regime at its Clyde refinery. with its wide "window of detection" and all that implies for interfering with the private lives of employees. Inhis view a more focussed method (saliva testing), is available where a positve test is far more likley to indicate actual impairment.
This conclusion was based on eveidence that drugs can be detected in urine well beyond the time the drug is having a significant biological effect. For example, the detection time for cannaboids in urine is 3 to 28 days, whereas for saliva it is up to 12 hours. For Meth, the detection time in urine is 2-5 days and only 24 hrs in saliva.
The decision was subject to 2 qualifications:
(a) Firstly, at this stage, no laboratories have as yet been accreditied under the relevant Australian Standards for saliva testing. It is understood this will change in the relatively near future.
(b) Secondly, there are drugs that the company may wish to test for (such as benzodiazapans) for which the Australian standard does not contain target concentration levels. The company should not be expected to implement a saliva testing regime until it has the agreement of the union and the testing lab on what other drugs it wishes to test for and what would be an appropriate target concentration level.
Will post remainder in the morning. Cant type any more